Invesco Dynamic Biotechnology & Genome ETF (PBE) ETF

Expense Ratio: 0.57% | AUM: 195.34M | Issuer: Invesco

PBE Daily Price Range
PBE 52-Week Price Range

PBE - Real-Time SMART Grade™


Overall SMART Grade

PBE has a real-time SMART Grade of C (Neutral).

Learn More About SMART Grades™

PBE - Profile & Info

The investment objective of the Invesco Dynamic Biotech & Genome ETF is based on the Dynamic Biotech & Genome Intellidex. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research.

Issuer Invesco
Expense Ratio 0.57%
Assets Under Management (AUM) 195.34M
Underlying Index Dynamic Biotechnology & Genome Intellidex Index
Asset Class Equity
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $46.51
Options? Yes
Total Holdings 61

PBE - Top Holdings

Symbol Holding Name % of Total
INCY Incyte Corp 6.00%
VRTX Vertex Pharmaceuticals Inc 5.28%
REGN Regeneron Pharmaceuticals Inc 5.28%
AMGN Amgen Inc 5.03%
BMRN BioMarin Pharmaceutical Inc 4.96%
BIIB Biogen Inc 4.92%
GILD Gilead Sciences Inc 4.73%
ALXN Alexion Pharmaceuticals Inc 4.48%
CORT Corcept Therapeutics Inc 3.08%
ALNY Alnylam Pharmaceuticals Inc 3.06%
INSM Insmed Inc 3.05%
PGNX Progenics Pharmaceuticals Inc 2.96%
ACOR Acorda Therapeutics Inc 2.93%
NBIX Neurocrine Biosciences Inc 2.86%
INVA Innoviva Inc 2.82%
SGEN Seattle Genetics Inc 2.78%
ARRY Array BioPharma Inc 2.75%
EXEL Exelixis Inc 2.74%
RGEN Repligen Corp 2.71%
ZIOP ZIOPHARM Oncology Inc 2.69%
EBS Emergent BioSolutions Inc 2.68%
LXRX Lexicon Pharmaceuticals Inc 2.62%
MYGN Myriad Genetics Inc 2.61%
CSII Cardiovascular Systems Inc 2.60%
UTHR United Therapeutics Corp 2.59%
OPK OPKO Health Inc 2.48%
IONS Ionis Pharmaceuticals Inc 2.44%
MNTA Momenta Pharmaceuticals Inc 2.38%
INSY Insys Therapeutics Inc 2.15%
ANIP ANI Pharmaceuticals Inc 2.06%
DYAX Dyax Corp 0.13%

PBE - Top Stories

View All PBE News

PBE - Price/Volume Stats

Current price $44.36
Prev. close $46.49
Day low $44.09
Day high $45.92
52-week high $57.60
52-week low $38.08
Day Volume 13,435
Avg. volume 13,481
Dividend yield 0.06%

PBE - Recent Returns

1-mo -14.99%
3-mo -20.50%
6-mo -6.78%
1-year -20.07%
3-year 5.49%
5-year -18.41%
YTD -20.52%
2019 18.65%
2018 -0.19%
2017 22.28%
2016 -22.90%
2015 1.72%

PBE - Stock Chart

PBE - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...

Get Free Updates

Join over 50,000 investors who get the latest news from!

Most Popular Articles

Page generated in 1.2651 seconds.